Serum ATG5 concentration relates to Th2 cell, nasal symptoms and therapeutic outcomes in allergic rhinitis patients.

Zhisheng Zheng, Ping Wang

Biomarkers in medicine 2023 Apr

filter terms:

Objective: This study aimed to explore the correlation of serum ATG5 levels with the disease risk, Th2/Th1 imbalance, symptoms and therapeutic outcomes of allergic rhinitis (AR) patients. Methods: Serum ATG5 levels in 160 AR patients, 30 disease controls and 30 healthy controls were measured by ELISA. AR patients received oral antihistamine, intranasal corticosteroid, leukotriene receptor antagonist monotherapy or their combination as needed for 4 weeks. Results: AR patients had elevated ATG5 levels compared with disease controls and healthy controls (p < 0.001). In AR patients, ATG5 levels were positively correlated with total nasal symptom scores, IL-4 levels and the IL-4/IFN-γ axis (all p < 0.05); the reduction in the ATG5 level was positively related to the total nasal symptom score decline from week 0 to week 4 (p = 0.038). Conclusion: Serum ATG5 levels have diagnostic and disease-monitoring value in AR management due to their relationship with Th2 cells and symptoms.

Citation

Zhisheng Zheng, Ping Wang. Serum ATG5 concentration relates to Th2 cell, nasal symptoms and therapeutic outcomes in allergic rhinitis patients. Biomarkers in medicine. 2023 Apr;17(8):437-444